Evidence map›Paper›PMID 42063743›Full record

ArticleJHLT open2026

Lung transplant outcomes in recipients waitlisted for both single and double lung transplantation.

Victoria Van Kirk, Shreya Guha, Ajay Prasad, William Zeng, Graeme M Rosenberg, Sean C Wightman, Brooks V Udelsman, Sivageni Ganesh, Scott M Atay, Anthony W Kim and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Victoria Van KirkKeck School of Medicine of the University of Southern California, Los Angeles, California.
Shreya GuhaCalifornia Northstate University College of Medicine, Elk Grove, California.
Ajay PrasadKeck School of Medicine of the University of Southern California, Los Angeles, California.
William ZengKeck School of Medicine of the University of Southern California, Los Angeles, California.
Graeme M RosenbergDivision of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Sean C WightmanDivision of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Brooks V UdelsmanDivision of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Sivageni GaneshDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Scott M AtayDivision of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Anthony W KimDivision of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Takashi HaranoDivision of Thoracic Surgery, Department of Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Double lung transplantation (DLTx) generally provides better survival than single lung transplantation (SLTx). However, SLTx recipients may often be more deconditioned, making direct comparisons challenging. The objective of this study is to investigate the transplant outcomes in patients waitlisted for both SLTx and DLTx to minimize differences in recipient background. Methods: The United Network for Organ Sharing Database was retrospectively analyzed. The patients who were waitlisted from December 2017 to February 2023, then removed from the waiting list in the same time periods, were included in the analysis. Pediatric lung transplantation, multiorgan transplantation, and lung retransplantation were excluded. Results: Of 4056 patients who were waitlisted for both SLTx and DLTx, 2127 patients (52.4%) received DLTx, 1351 patients (33.3%) received SLTx, and 578 patients (14.3%) were removed from waiting list without receiving lung transplantation. Median days on the waitlist were 36 days (IQR 12-93) for DLTx and 43 days (IQR 15-120) for SLTx. The lung allocation score at the time of transplantation was higher in DLTx group (50.58 ± 19.02 vs 44.67 ± 14.80, Conclusions: Among patients waitlisted for both DLTx and SLTx, DLTx recipients had lower post-transplant mortality, despite a more complicated immediate postoperative course compared to SLTx.

Indexed as

double lung transplantationOPTNoverall survivalsingle lung transplantationUNOS

Identifiers

PMID42063743
PMCPMC13126464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.